74
Views
9
CrossRef citations to date
0
Altmetric
Original article

Atopic dermatitis – topical therapy: Do patients apply much too little?

, , &
Pages 95-101 | Received 22 Jul 2003, Accepted 16 Dec 2004, Published online: 12 Jul 2009
 

Abstract

Background: The treatment of atopic dermatitis still remains a challenge. Little research has been done on the issue of the extent to which patients correctly use prescribed topical preparations under everyday conditions. Aims: To investigate what quantity of topical preparations is applied by outpatients in daily routine treatment over a 26‐week period and to what extent this consumption is related to the course of the severity of patients' skin conditions. Methods: Thirty adult outpatients (20 female and 10 male) with atopic dermatitis were examined at four different times during 26 weeks. For treatment and skin care these patients were given a topical glucocorticoid preparation (prednicarbate) and the corresponding emollient. Results: The average severity rating (SCORAD) was 29.6 (before therapy 33.9, after 26 weeks 27.4). The SCORAD indices improved by a mean of 6.5 points (p<0.05). Conclusion: Patients who applied the correct amount of the prednicarbate‐containing preparations (not less than 90% of 0.5 g/dm2) to the areas of affected skin showed a significant improvement in SCORAD indices across the four measuring times.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.